EDAP TMS S.A. Stock

Equities

EDAP

US2683111072

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
7.26 USD +1.82% Intraday chart for EDAP TMS S.A. -4.10% +37.50%
Sales 2024 * 72.35M Sales 2025 * 82.27M Capitalization 269M
Net income 2024 * -11M Net income 2025 * -8M EV / Sales 2024 * 3.72 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 3.27 x
P/E ratio 2024 *
-23.1 x
P/E ratio 2025 *
-33.1 x
Employees 307
Yield 2024 *
-
Yield 2025 *
-
Free-Float 33.22%
More Fundamentals * Assessed data
Dynamic Chart
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher MT
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading MT
Transcript : EDAP TMS S.A., Q4 2023 Earnings Call, Mar 27, 2024
EDAP TMS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
EDAP TMS S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading MT
EDAP TMS SA Announces FDA Breakthrough Device Designation for Focal One in the Treatment of Deep Infiltrating Rectal Endometriosis CI
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Wednesday Trading MT
More news
1 day+1.82%
1 week-4.10%
Current month-1.22%
1 month-3.84%
3 months+18.82%
6 months+9.83%
Current year+37.50%
More quotes
1 week
7.02
Extreme 7.02
7.73
1 month
6.81
Extreme 6.81
8.50
Current year
5.04
Extreme 5.0375
8.50
1 year
3.60
Extreme 3.6
12.23
3 years
3.60
Extreme 3.6
12.65
5 years
1.46
Extreme 1.46
12.65
10 years
1.15
Extreme 1.15
12.65
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-04-30
Chairman 54 97-04-30
Chief Operating Officer - 20-12-31
Members of the board TitleAgeSince
Director/Board Member 62 Dec. 05
Chairman 54 97-04-30
Director/Board Member 63 20-06-29
More insiders
Date Price Change Volume
24-04-19 7.26 +1.82% 6,701
24-04-18 7.13 -3.13% 68,828
24-04-17 7.36 +0.82% 12,620
24-04-16 7.3 -1.75% 24,266
24-04-15 7.43 -1.85% 25,787

Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT

More quotes
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.26 USD
Average target price
13.33 USD
Spread / Average Target
+83.65%
Consensus